ProCE Banner Activity

Currently Approved Immunotherapy After Progression

Slideset Download
In this downloadable slideset, Elizabeth R. Plimack, MD, MS, discusses the data on recent approvals for immune checkpoint inhibitors for patients with advanced bladder cancer who have progressed on previous therapy.

Released: February 14, 2018

Expiration: February 13, 2019

No longer available for credit.

Share

Supporters

Astellas Text

Merck Oncology

Seagen

Partners

BCAN

ProCE Banner